Wuxi Biologics Grants Restricted Shares to Motivate Employee

An announcement from Wuxi Biologics (Cayman) ( (HK:2269) ) is now available.

Wuxi Biologics has announced the grant of 64,117 Restricted Shares under its Restricted Share Award Scheme to an independent third-party employee. This initiative is designed to motivate the grantee by offering a personal stake in the company, aligning with Wuxi Biologics’ customary practice of equity-based remuneration. The shares will vest over a five-year period, with a clawback mechanism in place for specific circumstances, ensuring the company’s interests are protected.

The most recent analyst rating on (HK:2269) stock is a Buy with a HK$30.94 price target. To see the full list of analyst forecasts on Wuxi Biologics (Cayman) stock, see the HK:2269 Stock Forecast page.

More about Wuxi Biologics (Cayman)

Wuxi Biologics (Cayman) Inc. is a company incorporated in the Cayman Islands, operating in the biotechnology industry. It focuses on providing biologics services, including drug discovery, development, and manufacturing, catering to pharmaceutical and biotech companies globally.

Average Trading Volume: 58,205,797

Technical Sentiment Signal: Buy

Current Market Cap: HK$100.5B

Find detailed analytics on 2269 stock on TipRanks’ Stock Analysis page.